A Comparison of different regimens of meglumine antimoniate in the treatment of visceral leishmaniasis, Southern Iran

摘要

Background: Visceral leishmaniasis (VL) or Kala-azar, a life-threatening parasitic infection, is the most frequent among the rural population and nomads in Northwest and southern Iran. Antimony (meglumine antimoniate) has been the therapeutic cornerstone which has been used in different regimens. This study was conducted to evaluate the different regimens ofmeglumine antimoniate (Glucantime) in VL patients, Southern Iran.